Literature DB >> 8864415

Prostacyclin (PGI2): a potential mediator of c-fos expression induced by hydrostatic pressure in osteoblastic cells.

H Glantschnig1, F Varga, M Rumpler, K Klaushofer.   

Abstract

Application of compressive forces to osteoblastic cells is known to cause specific cellular responses. We report that hydrostatic pressure increased c-fos mRNA expression in MC3T3-E1 cells after 15, 30 and 60 min. This effect was absent when 5 x 10(-7) mol L-1 indomethacin, an inhibitor of prostaglandin synthesis, was present in the culture medium during pressurization. Using radioimmunoassay, a significant increase in the concentrations of 6-keto-PGF1 alpha, the stable conversion product of prostacyclin (PGI2), in the conditioned medium of pressurized cells, was measured after 60 min. In contrast, PGE2 levels were not significantly changed and we therefore assume that under these experimental conditions PGE2 is not responsible for the transduction of the hydrostatic force. However, we also found that PGE2 has the capacity to induce c-fos mRNA in MC3T3-E1 cells. Furthermore, we show for the first time that the stable prostacyclin analogue, Iloprost-Trometamol (Ilomedin), is a potent activator of c-fos gene transcription. Our data suggest that prostacyclin is a likely candidate in mediating the effect of hydrostatic compressive stress on bone cells by regulating the level of c-fos mRNA, a member of the activator protein (AP-1) complex and potent regulator of osteoblastic proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864415     DOI: 10.1046/j.1365-2362.1996.165312.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.

Authors:  Zachary C Ryan; Theodore A Craig; Jeffrey L Salisbury; Lomeli R Carpio; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-04-26       Impact factor: 3.575

2.  A Platform for Studying of the Three-Dimensional Migration of Hematopoietic Stem/Progenitor Cells.

Authors:  Eunjin Lee; Jieun Kim; Yungyeong Kang; Jung-Woog Shin
Journal:  Tissue Eng Regen Med       Date:  2019-11-19       Impact factor: 4.169

3.  Nitric oxide and prostaglandins potentiate the liver regeneration cascade.

Authors:  Jodi M Schoen Smith; W Wayne Lautt
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

4.  Responses of different cell lines from ocular tissues to elevated hydrostatic pressure.

Authors:  M B Wax; G Tezel; S Kobayashi; M R Hernandez
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

5.  Manipulation of Suspended Single Cells by Microfluidics and Optical Tweezers.

Authors:  Nathalie Nève; Sean S Kohles; Shelley R Winn; Derek C Tretheway
Journal:  Cell Mol Bioeng       Date:  2010-09-01       Impact factor: 2.321

6.  Compression induces Ephrin-A2 in PDL fibroblasts via c-fos.

Authors:  S Sen; K Diercke; S Zingler; C J Lux; R Erber
Journal:  J Dent Res       Date:  2015-01-20       Impact factor: 6.116

7.  Cyclic Hydraulic Pressure and Fluid Flow Differentially Modulate Cytoskeleton Re-Organization in MC3T3 Osteoblasts.

Authors:  Joseph D Gardinier; Shyama Majumdar; Randall L Duncan; Liyun Wang
Journal:  Cell Mol Bioeng       Date:  2009-03-01       Impact factor: 2.321

8.  Centrifugal forces within usually-used magnitude elicited a transitory and reversible change in proliferation and gene expression of osteoblastic cells UMR-106.

Authors:  Juan Li; Lingyong Jiang; Ga Liao; Guoping Chen; Ying Liu; Jun Wang; Yi Zheng; Songjiao Luo; Zhihe Zhao
Journal:  Mol Biol Rep       Date:  2007-11-23       Impact factor: 2.316

9.  Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.

Authors:  C E Evans; S Mylchreest; J G Andrew
Journal:  BMC Musculoskelet Disord       Date:  2006-03-06       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.